Gelonghui November 22nd | Shanghai haixin group (600851.SH) stated on the investor interaction platform that shanghai haixin biotechnology co., ltd. does not involve AI medicine in its operation scope.
海欣股份(600851.SH):上海海欣生物技术有限公司经营范围不涉及AI医药
shanghai haixin group (600851.SH): shanghai haixin biotechnology co., ltd. operation does not involve AI medicine
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.